Han, R., Chen, L., Chen, P., Song, T. (2025). Tislelizumab as monotherapy or in sequential combination with lenvatinib for neoadjuvant treatment of resectable hepatocellular carcinoma: A prospective, phase II clinical study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16292